BioCentury
ARTICLE | Company News

Beyond Genomics, GlaxoSmithKline deal

February 2, 2004 8:00 AM UTC

GSK agreed to fund research by Beyond Genomics to identify biomarkers for metabolic diseases. Under the deal, Beyond Genomics receives an upfront fee and is eligible for milestones. Beyond Genomics al...